<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="153449">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01102374</url>
  </required_header>
  <id_info>
    <org_study_id>09-0899</org_study_id>
    <secondary_id>IND 106541</secondary_id>
    <nct_id>NCT01102374</nct_id>
  </id_info>
  <brief_title>Vitamin D Supplementation and Acute Respiratory Infection in Older Long-Term Care Residents</brief_title>
  <official_title>Vitamin D Supplementation and Acute Respiratory Infection in Older Long-Term Care Residents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>The American Geriatrics Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the role of high dose vitamin D supplementation in prevention of acute
      respiratory infection in older nursing home residents. The investigators hypothesize that
      residents on high dose vitamin D supplementation will have a lower incidence of acute
      respiratory infection that those on standard dose vitamin D supplementation.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of acute respiratory infections (ARIs)</measure>
    <time_frame>12 months</time_frame>
    <description>ARIs defined as upper or lower respiratory infections</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severity of acute respiratory infections</measure>
    <time_frame>12 month</time_frame>
    <description>ARIs resulting in emergency department visits or hospitalizations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first ARI</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 25-hydroxyvitamin D (25OHD) level</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in parathyroid hormone level</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Falls</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fractures</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of upper respiratory infections</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of lower respiratory infections</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of influenza-like illnesses</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incident kidney stones</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incident hypercalcemia</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of urinary tract infections</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of other infections</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Vitamin D</condition>
  <condition>Respiratory Infection</condition>
  <arm_group>
    <arm_group_label>High Dose Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Dose Vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High Dose Vitamin D</intervention_name>
    <description>Vitamin D3 100,000 IU monthly</description>
    <arm_group_label>High Dose Vitamin D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard Dose Vitamin D</intervention_name>
    <description>Vitamin D 400-1000 IU per day</description>
    <arm_group_label>Standard Dose Vitamin D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 60+ years

          -  Resides in nursing home

        Exclusion Criteria:

          -  Terminal illness (expected survival &lt;6 months)

          -  Anticipated discharge within 12 months

          -  Unable to take whole or crushed tablets

          -  Active cancer, except squamous/basal cell carcinoma

          -  Severe malnutrition (body mass index &lt;18 kg/m2)

          -  Current immunosuppressive medications (including corticosteroids)

          -  Renal failure (estimated glomerular filtration rate &lt; 15 mL/min/1.73m2)

          -  Currently taking &gt;1,000 IU/d vitamin D supplementation

          -  History (or strong family history) of kidney stones

          -  History of sarcoidosis or other granulomatous disorders associated with hypercalcemia

          -  Elevated baseline hypercalcemia (albumin-adjusted serum calcium &gt;10.5 mg/dL)

          -  Baseline serum 25OHD level â‰¥ 100 nmol/L

          -  Inability to provide informed consent and no available healthcare legally authorized
             representative

          -  Inability of participant or legally authorized representative to speak/understand
             English
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adit A Ginde, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <lastchanged_date>May 26, 2015</lastchanged_date>
  <firstreceived_date>April 11, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Respiratory Infection</keyword>
  <keyword>Nursing Home Residents</keyword>
  <keyword>Geriatrics</keyword>
  <keyword>Immunosenescence</keyword>
  <keyword>Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
